GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » LT-Debt-to-Total-Asset

Cognetivity Neurosciences (XCNQ:CGN) LT-Debt-to-Total-Asset : 2.81 (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Cognetivity Neurosciences's long-term debt to total assests ratio for the quarter that ended in Oct. 2023 was 2.81.

Cognetivity Neurosciences's long-term debt to total assets ratio increased from Oct. 2022 (0.25) to Oct. 2023 (2.81). It may suggest that Cognetivity Neurosciences is progressively becoming more dependent on debt to grow their business.


Cognetivity Neurosciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Cognetivity Neurosciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences LT-Debt-to-Total-Asset Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial - - - - -

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 - - - 2.81

Cognetivity Neurosciences LT-Debt-to-Total-Asset Calculation

Cognetivity Neurosciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2023 is calculated as

LT Debt to Total Assets (A: Jan. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Jan. 2023 )/Total Assets (A: Jan. 2023 )
=0/2.829
=0.00

Cognetivity Neurosciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Oct. 2023 is calculated as

LT Debt to Total Assets (Q: Oct. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Oct. 2023 )/Total Assets (Q: Oct. 2023 )
=1.368/0.487
=2.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (XCNQ:CGN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Cognetivity Neurosciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (XCNQ:CGN) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines